Physician profile
Emmanuel Achu
NPI 1891112140
$5,530.05
in general payments reported to CMS, 2019-2025
26 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,825 · 2020: $690 · 2021: $1,198 · 2022: $1,019 · 2023: $279 · 2024: $419 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,151.25 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $652.81 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $535.15 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $475.74 | 2019-2025 | Repatha |
| Medtronic, INC. | $451.20 | 2021-2023 | Micra |
| Astrazeneca Pharmaceuticals Lp | $380.26 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $296.67 | 2019 | |
| Abbott Laboratories | $276.29 | 2019-2022 | |
| Biosense Webster, INC. | $227.62 | 2022-2024 | Carto 3 |
| Pfizer INC. | $179.67 | 2019-2022 | |
| Cook Medical LLC | $133.74 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $120.13 | 2021-2022 | |
| Medtronic Vascular, INC. | $119.30 | 2020 | |
| Kestra Medical Technology Services, INC. | $83.40 | 2024 | Assure Wcd |
| Philips North America LLC | $71.64 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $63.68 | 2021-2025 | Flexitouch Plus, Nimbl |
| Novartis Pharmaceuticals Corporation | $54.01 | 2022-2023 | |
| Esperion Therapeutics, INC. | $47.18 | 2022 | |
| Lantheus Medical Imaging, INC. | $45.98 | 2019-2020 | |
| Heartflow, INC. | $33.34 | 2022 | |
| Imbed Biosciences INC. | $29.11 | 2022 | |
| Lilly USA, LLC | $26.82 | 2023 | Mounjaro |
| Alnylam Pharmaceuticals INC. | $24.25 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.96 | 2022 | |
| Allergan, INC. | $16.69 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.16 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Achu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.